XML 33 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Common Stock
Add'l Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Unearned ESOP
Treasury Stock, Common
Beginning balance at Dec. 31, 2020   $ 8 $ 7,595 $ 16,361 $ (10,855) $ (49) $ (625)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issued/sold     320        
Stock-based compensation and allocation of ESOP shares     236     34  
APIC, Stock Issued During Period, Value, Treasury Reissued - compensation and benefit plans     0        
Other     0 (22)      
Net income available for The Dow Chemical Company common stockholder $ 6,311     6,311      
Dividends to stockholders       (2,073)      
Settlements and transfers related to separation from DowDuPont Inc.       46      
Other comprehensive income (loss) 1,878       1,878    
Treasury stock purchases             (1,000)
Stock Issued During Period, Value, Treasury Stock Reissued - compensation and benefit plans             0
Ending balance at Dec. 31, 2021 $ 18,739 8 8,151 20,623 (8,977) (15) (1,625)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share of common stock $ 2.80            
Dow Inc.’s stockholders’ equity $ 18,165            
Noncontrolling interests 574            
Common stock issued/sold     212        
Stock-based compensation and allocation of ESOP shares     258     15  
APIC, Stock Issued During Period, Value, Treasury Reissued - compensation and benefit plans     (79)        
Other     (2) (19)      
Net income available for The Dow Chemical Company common stockholder 4,582     4,582      
Dividends to stockholders       (2,006)      
Settlements and transfers related to separation from DowDuPont Inc.       0      
Other comprehensive income (loss) 1,838       1,838    
Treasury stock purchases             (2,325)
Stock Issued During Period, Value, Treasury Stock Reissued - compensation and benefit plans             79
Ending balance at Dec. 31, 2022 $ 21,247 8 8,540 23,180 (7,139) 0 (3,871)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share of common stock $ 2.80            
Dow Inc.’s stockholders’ equity $ 20,718            
Noncontrolling interests 529            
Common stock issued/sold     188        
Stock-based compensation and allocation of ESOP shares     276     0  
APIC, Stock Issued During Period, Value, Treasury Reissued - compensation and benefit plans     (124)        
Other     0 (23)      
Net income available for The Dow Chemical Company common stockholder 589     589      
Dividends to stockholders       (1,972)      
Settlements and transfers related to separation from DowDuPont Inc.       0      
Other comprehensive income (loss) (542)       (542)    
Treasury stock purchases             (627)
Stock Issued During Period, Value, Treasury Stock Reissued - compensation and benefit plans             124
Ending balance at Dec. 31, 2023 $ 19,108 $ 8 $ 8,880 $ 21,774 $ (7,681) $ 0 $ (4,374)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share of common stock $ 2.80            
Dow Inc.’s stockholders’ equity $ 18,607            
Noncontrolling interests $ 501